StockNews.AI
STXS
StockNews.AI
197 days

Stereotaxis to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

1. Stereotaxis will release Q4 2024 results on March 3, 2025. 2. Conference call planned for detailed discussion at 8:30 a.m. ET. 3. Stereotaxis specializes in robotic systems for minimally invasive procedures. 4. Over 150,000 patients treated globally with Stereotaxis technology. 5. Past performance illustrates growth potential in robotic surgery market.

4m saved
Insight
Article

FAQ

Why Bullish?

The scheduled earnings release indicates ongoing business progress, potentially leading to positive investor sentiment. Historically, strong earnings reports in similar firms have resulted in stock price increases.

How important is it?

As a key earnings report, it will provide insights into company performance, influencing investor decisions and market perception.

Why Short Term?

The earnings call can lead to immediate price movements based on performance disclosure. Short-term fluctuations often follow financial results announcements.

Related Companies

NYSE: STXSNYSE: ISRGNYSE: MDT
ST. LOUIS, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2024 fourth quarter and full year on Monday, March 3, 2025 before the open of the U.S. financial markets. The Company will host a conference call and webcast at 8:30 a.m. ET that day to discuss the Company’s results and corporate developments. What:Stereotaxis fourth quarter and full year 2024 financial results conference call  When:Monday, March 3, 2025 at 8:30 a.m. ET (5:30 a.m. PT)  Dial In Number:To access the live call, dial 800-715-9871 (US and Canada) or 1-646-307-1963 (International) and give the participant pass code 1983976.  Webcast:To access the live and replay webcast, please visit the investor relations section of Stereotaxis’ website at http://ir.stereotaxis.com/.  Call Replay:A phone replay of the call will be available for one month beginning approximately four hours following the end of the call. To request access for a replay of the conference call, please click here. About Stereotaxis Stereotaxis (NYSE: STXS) is a pioneer and global leader in innovative surgical robotics for minimally invasive endovascular intervention. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, expand access to minimally invasive therapy, and enhance the productivity, connectivity, and intelligence in the operating room. Stereotaxis technology has been used to treat over 150,000 patients across the United States, Europe, Asia, and elsewhere. For more information, please visit www.stereotaxis.com. Investor Contacts:David L. FischelChairman and Chief Executive Officer                                                        Kimberly Peery                                                Chief Financial Officer 314-678-6100Investors@Stereotaxis.com

Related News